DISEASE INDICATIONS: Leukemia, Lymphoma, Rheumatoid Arthritis, Granulomatosis, Polyangiitis

MANUFACTURER: Celltrion Healthcare Hungary Kft / Teva Pharmaceuticals

USAGE: Intravenous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Medsafe (NZ)

Truxima (rituximab) is a drug prescribed for the treatment of follicular lymphoma and diffuse large B-cell non-Hodgkin’s lymphoma (NHL), chronic lymphocytic leukemia (CLL), severe active rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis.